Catalyst Pharmaceuticals Inc Cash Flow Quality Index
Catalyst Pharmaceuticals Inc cash flow quality index. Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow Quality Index of 0.93x as of March 2026. Operating cash flow of $59.59 Million is below net income of $63.73 Million, suggesting accrual-heavy earnings not yet converted to cash. See CPRX free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Catalyst Pharmaceuticals Inc (2019–2025)
Cash flow quality index of Catalyst Pharmaceuticals Inc from 2019 to 2025. Historical Cash Flow Quality Index for Catalyst Pharmaceuticals Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore how well can Catalyst Pharmaceuticals Inc service its debt to assess how comfortably operating cash covers total debt obligations.
Catalyst Pharmaceuticals Inc Cash Flow Quality Index by Year (2019–2025)
Catalyst Pharmaceuticals Inc cash flow quality index by year from 2019 to 2025. Year-by-year earnings quality comparison for Catalyst Pharmaceuticals Inc. For the full cash flow conversion analysis, see Catalyst Pharmaceuticals Inc operating cash flow efficiency.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.97x | $208.67 Million | $214.33 Million | ▼ -33.5% |
| 2024 | 1.46x | $239.81 Million | $163.89 Million | ▼ -27.2% |
| 2023 | 2.01x | $143.60 Million | $71.41 Million | ▲ +44.0% |
| 2022 | 1.40x | $116.05 Million | $83.08 Million | ▼ -8.7% |
| 2021 | 1.53x | $60.37 Million | $39.48 Million | ▲ +154.6% |
| 2020 | 0.60x | $45.03 Million | $74.98 Million | ▼ -44.7% |
| 2019 | 1.09x | $34.61 Million | $31.88 Million | — |